1. Home
  2. AHL vs MLYS Comparison

AHL vs MLYS Comparison

Compare AHL & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aspen Insurance Holdings Limited Class A Ordinary Shares

AHL

Aspen Insurance Holdings Limited Class A Ordinary Shares

N/A

Current Price

$37.02

Market Cap

3.4B

Sector

Finance

ML Signal

N/A

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$38.73

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AHL
MLYS
Founded
2002
2019
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.1B
IPO Year
2025
2023

Fundamental Metrics

Financial Performance
Metric
AHL
MLYS
Price
$37.02
$38.73
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$39.44
$46.40
AVG Volume (30 Days)
241.6K
1.9M
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
33.46
N/A
EPS
6.60
N/A
Revenue
$3,191,700,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.24
N/A
P/E Ratio
$5.61
N/A
Revenue Growth
5.65
N/A
52 Week Low
$27.05
$8.24
52 Week High
$37.19
$47.65

Technical Indicators

Market Signals
Indicator
AHL
MLYS
Relative Strength Index (RSI) N/A 42.94
Support Level N/A $41.50
Resistance Level N/A $44.13
Average True Range (ATR) 0.00 2.37
MACD 0.00 -0.63
Stochastic Oscillator 0.00 15.49

Price Performance

Historical Comparison
AHL
MLYS

About AHL Aspen Insurance Holdings Limited Class A Ordinary Shares

Aspen Insurance Holdings Ltd is a Bermudian insurance and reinsurance company. Its principal business is marketing and underwriting specialty insurance and reinsurance regularly. It comprises underwriting operations, which include risk-bearing insurance and reinsurance operations; Investing activities, which support underwriting operations; and ACM operations, which earn underwriting, management, and performance fees. It has two segments: Aspen Insurance and Aspen Reinsurance. Aspen Insurance consists of property and casualty insurance, marine, aviation, and energy insurance, and financial and professional lines insurance. Aspen Reinsurance comprises property catastrophe reinsurance, other property reinsurance, casualty reinsurance, and specialty reinsurance.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: